BKD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Brookdale Senior Living Inc (BKD) is not an ideal buy for a beginner investor with a long-term strategy right now. The stock is underperforming with declining financials, negative technical indicators, and no strong positive catalysts to support immediate growth. While analysts have raised price targets and maintain positive ratings, the company's recent financial performance and hedge fund selling trends suggest caution.
The MACD histogram is negative and expanding (-0.262), indicating bearish momentum. RSI is neutral at 31.035, but close to oversold territory. Moving averages are converging, showing no clear trend. The stock is trading below its pivot level (15.1), with support at 14.634 and resistance at 15.566. Overall, the technical indicators suggest a bearish trend.
Analysts have raised price targets significantly over the past two months, citing mid-teens EBITDA growth, improving occupancy rates, and disciplined pricing strategies. Gross margin increased by 16.49% YoY in Q4 2025.
Hedge funds are aggressively selling, with an 885.30% increase in selling activity last quarter. Financial performance in Q4 2025 showed a YoY decline in revenue (-3.44%), net income (-52.38%), and EPS (-54.05%). No recent news or congress trading activity to support a positive outlook. The stock has a 70% chance of declining further in the short term based on candlestick analysis.
In Q4 2025, revenue dropped to $754.09M (-3.44% YoY), net income fell to -$39.96M (-52.38% YoY), and EPS decreased to -$0.17 (-54.05% YoY). However, gross margin improved to 14.69% (+16.49% YoY), indicating some operational efficiency gains.
Analysts maintain positive ratings, with multiple upgrades and price target increases. The latest price targets range from $15 to $19.50, reflecting optimism about mid-teens EBITDA growth and occupancy gains. However, these ratings are based on long-term potential rather than immediate performance.
